Silymarin suppress CD4+ T cell activation and proliferation: Effects on NF-κB activity and IL-2 production
Marjan GharagozlooDepartment of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranEnrico VelardiDepartment of Clinical and Experimental Medicine, Section of Pharmacology, Perugia University Medical School, Perugia, ItalyStefano BruscoliDepartment of Clinical and Experimental Medicine, Section of Pharmacology, Perugia University Medical School, Perugia, ItalyMassimiliano AgostiniDepartment of Clinical and Experimental Medicine, Section of Pharmacology, Perugia University Medical School, Perugia, ItalyMoises Di SanteDepartment of Clinical and Experimental Medicine, Section of Pharmacology, Perugia University Medical School, Perugia, ItalyValerio DonatoDepartment of Clinical and Experimental Medicine, Section of Pharmacology, Perugia University Medical School, Perugia, ItalyZahra AmirghofranDepartment of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IranCarlo RiccardiDepartment of Clinical and Experimental Medicine, Section of Pharmacology, Perugia University Medical School, Perugia, Italy
2010en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 3Использованных источников: 0